NCT00335673View on ClinicalTrials.gov

I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

1,630

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Hypertension
Interventions
DRUG

Irbesartan (Aprovel)

Aprovel (150 \& 300mg) \& CoAprovel (300/12.5mg hydrochlorothiazide) one tablet a day per os.

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Cairo

Sponsors

Lead Sponsor

Sanofi

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Sanofi

INDUSTRY

NCT00335673 - I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients | Biotech Hunter | Biotech Hunter